Danish and US device certification agreement signed
This article was originally published in Clinica
Executive Summary
Denmark's Notified Body, DGM, the Danish Standards Association (DS) and US Notified Body Underwriters Laboratories have signed a reciprocal device certification agreement. The deal allows DGM to provide Scandinavian manufacturers with information and support on the FDA's 510(k) third-party review programme in which UL evaluates applications and submits a recommendation to the FDA on US marketing.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.